Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis
Advanced Science · 2025
DOI: 10.1002/advs.202416711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Hong Li und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH, 43210, USA. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Membrane Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Small cell lung cancer (SCLC) is associated with high mortality and limited therapeutic options. There is increasing recognition that SCLC harbors molecular heterogeneity. Using a new liquid biopsy assay, it is demonstrated that SCLC subtypes, as determined by patient tumor tissue staining and cell lines, can be accurately identified by measuring the mRNA expression of subtype transcription factors (ASCL1, POU2F3, and NEUROD1) in circulating exosome‐rich extracellular vesicles (Exo). Additionally, upregulation of Delta‐like ligand 3 (DLL3) mRNA in Exo and its membrane protein (mProtein) in extracellular vesicles associated with tumor (tEV) may distinguish both limited‐ and extensive‐stage SCLC patients from high‐risk smokers, with AUC/ROC values of 0.836 and 0.839, respectively. By incorporating Exo‐ASCL1 and Exo‐POU2F3 mRNA expression with DLL3 Exo‐mRNA/tEV‐mProtein expression, the classifier enhances the AUC/ROC to 0.912 and 0.963 for limited‐ and extensive‐stage SCLC patients, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH, 43210, USA.
- Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan.
- Spot Biosystems Ltd., Columbus, OH, 43212, USA.
- Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
- Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, 11031, Taiwan.
- Genomic Research Center, Academia Sinica, Taipei, 11529, Taiwan.
ORCID-Profile: L James Lee
Förderung
- National Science and Technology Council
- NCATS NIH HHS
- NCI NIH HHS
- Yushan Fellow Program by the Ministry of Education
- Melissa Lee Cancer Foundation
- Taipei Veterans General Hospital
- Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang-Ming University
- Ministry of Education
Zitieren
APA
Li, H., Chiang, C. L., Kwak, K. J., Lee, H. L., Wang, X., Romano, G., Saviana, M., Toft, R., Cheng, T. S., Chang, Y., Hsiang, B. D., Liu, G. W., Mo, X., Ma, Y., Pan, J., Rima, X. Y., Kim, T. N., Reategui, E., Shen, C. N., …, & Lee, L. J. (2025). Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis. Advanced Science. https://doi.org/10.1002/advs.202416711
Vancouver
Li H, Chiang CL, Kwak KJ, Lee HL, Wang X, Romano G, et al. Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis. Advanced Science. 2025. doi:10.1002/advs.202416711
BibTeX
@article{Li2025,
author = {Li, Hong and Chiang, Chi-Ling and Kwak, Kwang Joo and Lee, Hsin-Lun and Wang, Xinyu and Romano, Giulia and Saviana, Michela and Toft, Robin and Cheng, Tai-Shan and Chang, Yuehshih and Hsiang, Bi-Da and Liu, Guan-Wan and Mo, Xiaokui and Ma, Yifan and Pan, Junjie and Rima, Xilal Y and Kim, Truc Nguyen and Reategui, Eduardo and Shen, Chia-Ning and Chu, Yeh-Shiu and Croce, Carlo and Chang, Peter Mu-Hsin and Yeh, Yi-Chen and Carbone, David P and Huang, Chi-Ying F and Chiang, Chi-Lu and Nana-Sinkam, Patrick and Lee, L James},
title = {Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202416711}
}
EUVIMED